European Heart Journal, volume 28, issue 19, pages 2375-2414
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
I. Graham
,
D Atar
,
K Borch-Johnsen
,
G Boysen
,
G Burell
,
R. Cifkova
,
J Dallongeville
,
G. DE BACKER
,
S. Ebrahim
,
B Gjelsvik
,
C Herrmann Lingen
,
A Hoes
,
S Humphries
,
M Knapton
,
Perk J
,
S G Priori
,
K Pyörälä
,
Z Reiner
,
L Ruilope
,
S Sans Menendez
,
W Scholte Op Reimer
,
P. Weissberg
,
D. Wood
,
J. Yarnell
,
E Walma
,
T Fitzgerald
,
M T Cooney
,
A. Dudina
,
A Vahanian
,
J Camm
,
R De Caterina
,
V. DEAN
,
K Dickstein
,
C Funck-Brentano
,
G. Filippatos
,
S. D. Kristensen
,
K. McGregor
,
U Sechtem
,
S Silber
,
M. Tendera
,
P. Widimský
,
J. L. Zamorano
,
I Hellemans
,
A Altiner
,
E. Bonora
,
P N Durrington
,
R Fagard
,
S Giampaoli
,
H. Hemingway
,
J Håkansson
,
S E Kjeldsen
,
M. L. Larsen
,
G Mancia
,
A. J. Manolis
,
K Orth-Gomér
,
T. Pedersen
,
M. Rayner
,
L Rydén
,
M. Sammut
,
N Schneiderman
,
A F Stalenhoef
,
L Tokgozoglu
,
O Wiklund
,
A. Zampelas
Publication type: Journal Article
Publication date: 2007-05-04
Journal:
European Heart Journal
scimago Q1
SJR: 4.091
CiteScore: 39.3
Impact factor: 37.6
ISSN: 0195668X, 15229645
PubMed ID:
17726041
Cardiology and Cardiovascular Medicine
Abstract
Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim to assist physicians in selecting the best management strategies for a typical patient, suffering from a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines are not substitutes for textbooks. The legal implications of medical guidelines have been discussed previously.
A great number of Guidelines and Expert Consensus Documents have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organizations. Because of the impact on clinical practice, quality criteria for development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines and Expert Consensus Documents can be found on the ESC web site (http://www.escardio.org/knowledge/guidelines/rules).
In brief, experts in the field are selected and undertake a comprehensive review of the published evidence for management and/or prevention of a given condition. A critical evaluation of diagnostic and therapeutic procedures is performed, including assessment of the risk–benefit ratio. Estimates of expected health outcomes for larger societies are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to predefined scales, as outlined in the tables below.
The experts of the writing panels have provided disclosure statements of all relationships they may have which might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at the European Heart House, headquarters of the ESC. Any changes in conflict of interest that arise during the writing period must be notified to the ESC. The Task Force report was entirely …
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.